1. Home
  2. TCPC vs NBY Comparison

TCPC vs NBY Comparison

Compare TCPC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$3.63

Market Cap

407.2M

Sector

Finance

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
NBY
Founded
2006
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
407.2M
398.2M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
TCPC
NBY
Price
$3.63
$1.18
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
1.3M
817.4K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
21.92%
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
N/A
$32.05
P/E Ratio
N/A
$1.67
Revenue Growth
N/A
N/A
52 Week Low
$3.64
$0.43
52 Week High
$8.11
$19.95

Technical Indicators

Market Signals
Indicator
TCPC
NBY
Relative Strength Index (RSI) 22.18 41.39
Support Level N/A $0.94
Resistance Level $5.99 $1.36
Average True Range (ATR) 0.15 0.21
MACD -0.03 0.15
Stochastic Oscillator 2.49 5.87

Price Performance

Historical Comparison
TCPC
NBY

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: